Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Donkees

(33,525 posts)
Sat Dec 18, 2021, 04:02 PM Dec 2021

This One Drug Will Make Medicare Premiums Skyrocket



Dec 16, 2021

Seniors will pay record-high Medicare premiums in 2022 after the FDA approved an Alzheimer’s drug that costs $56,000 over the objections of medical advisors. There is zero evidence that the drug cures or reverses Alzheimer's. Three FDA administrators quit in protest.

Biden must act stop this outrageous increase in Medicare premiums.
18 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies

NewHendoLib

(61,700 posts)
1. it already did. we got our part B bills - up 20.00 per month just for this one drug
Sat Dec 18, 2021, 04:16 PM
Dec 2021

ridiculous

so if they reverse it, they'd have to offer refunds to make it fair.

 

Hoyt

(54,770 posts)
3. Three FDA docs quitting because they didn't get their way is not surprising.
Sat Dec 18, 2021, 04:46 PM
Dec 2021

I’m hopeful the drug, and treatments that may come about, will work.

Elwood P Dowd

(11,453 posts)
8. Biden has yet to appoint someone to head the FDA.
Sat Dec 18, 2021, 06:35 PM
Dec 2021

The acting commissioner is Janet Woodcock. Why did she let this happen? Anyone know the details?

Donkees

(33,525 posts)
11. 'At the eleventh hour, Woodcock shunned by Biden as Califf becomes FDA commish nominee'
Sat Dec 18, 2021, 07:11 PM
Dec 2021

Nov 12, 2021

President Joe Biden has officially nominated former Obama administration pick Robert Califf, M.D., as his new FDA commissioner.

This comes right before Nov. 15, the final day Janet Woodcock, M.D., the acting commissioner, can stay in the interim role, and 10 months after Biden’s inauguration.

An FDA veteran, Woodcock has two stints heading up the Center for Drug Evaluation and Research—from 2008 until now and from 1994 to 2005. In between, she served in the FDA commissioner’s office. Most recently she served as part of Operation Warp Speed, overseeing COVID-19 therapy development.

She had initially been seen as a favorite to take the top job on a full-time basis but appeared to lose confidence from some key Washington insiders after the approval of Biogen’s expensive and controversial Alzheimer’s drug Aduhlem.

https://www.fiercebiotech.com/biotech/at-eleventh-hour-woodcock-shunned-by-biden-as-recycled-pick-califf-becomes-fda-commis

appalachiablue

(43,944 posts)
9. First Human Trial of Alzheimer's Nasal Vaccine To Prevent & Slow Disease:
Sat Dec 18, 2021, 06:44 PM
Dec 2021

- 'First human trial of Alzheimer's disease nasal vaccine to begin at Boston hospital, CBS News, Nov. 16, 21

Brigham and Women's Hospital will test the safety and efficacy of a nasal vaccine aimed at preventing and slowing Alzheimer's disease, the Boston hospital announced Tuesday. The start of the small, Phase I clinical trial comes after nearly 20 years of research led by Howard L. Weiner, MD, co-director of the Ann Romney Center for Neurologic Diseases at the hospital.

The trial will include 16 participants between the ages of 60 and 85, all with early symptomatic Alzheimer's but otherwise generally healthy. They will receive two doses of the vaccine one week apart, the hospital said in a press release. The participants will enroll from the Ann Romney Center.

A Phase I clinical trial is designed to establish the safety and dosage for a potential new medication. If it goes well, a much larger trial would be needed to test its effectiveness.

https://www.cbsnews.com/news/alzheimers-disease-nasal-vaccine-human-trial-to-begin-at-boston-hospital/

Latest Discussions»General Discussion»This One Drug Will Make M...